Form 4: NextCure Executive Acquires Stock Options
SEC Form 4
Timothy Mayer, Chief Operating Officer of NextCure, Inc., reports the acquisition of employee stock options.
Summary
- On March 29, 2024, Timothy Mayer, the Chief Operating Officer of NextCure, Inc., acquired 93,900 employee stock options with an exercise price of $2.23.
- The options vest fully on March 29, 2025, one year after the grant date.
- Following the transaction, Mayer directly owns 93,900 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard Form 4 filing indicating an executive's acquisition of stock options, which can be seen as a positive sign of confidence but doesn't inherently guarantee future performance.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment of interests.
Stakeholder Impact
- Shareholders may view the acquisition of stock options by the COO as a positive sign, aligning his interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of the transaction: Timothy Mayer acquired employee stock options. |
| 03/29/2025 | Vesting date: The acquired stock options vest in full. |
| 03/28/2034 | Expiration date of the options. |
| 04/02/2024 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.